High-concentration protein formulations: How high is high? Some reflections on feasibility

16:05 - 16:35

 

  • Between clinical desires and physico-chemical reality
  • The ongoing challenges …
  • Current topics related to HCLF biologics
  • Same related case studies

Patrick Garidel, Associate Director Protein Science, Boehringer Ingelheim